Prosecution Insights
Last updated: April 19, 2026

Diospharma Co. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17659348 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RETINAL DEGENERATIVE DISEASE, COMPRISING HUMAN NEURAL CREST-DERIVED NASAL INFERIOR TURBINATE STEM CELLS AS ACTIVE INGREDIENT WANG, CHANG YU 1675 Final Rejection Apr 15, 2022

Managing Diospharma Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month